Worldwide In Vitro Diagnostics (IVD) Market Forecasted to Grow at 4% p.a., Reaching $109B by 2030 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, “In Vitro Diagnostic (IVD) Market Report 2025-2030”, the global in vitro diagnostics market is predicted to reach $109B by 2030. This growth will be driven by increasing access to and adoption of diagnostics, the development of new therapies requiring ongoing testing, and the rise of emerging technologies (e.g., computational pathology, liquid biopsy) poised to gain clinical traction and improve patient care.
Proteomics Tools Market Forecast to Grow at ~4% p.a., Reaching ~$39B by 2030 – Market Report by DeciBio Consulting LLC
DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Proteomics Tools Report: Research and Clinical markets (2025-2030).” This comprehensive report forecasts the global proteomics tools market to reach approximately $39 billion by 2030, growing at a compound annual growth rate (CAGR) of ~4% from an estimated $32 billion in 2025.
Pharma R&D Services Market Forecast to Grow at 5% p.a., Reaching ~$129B by 2029 – Market Report by DeciBio Consulting LLC
DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Pharma R&D Services Market Report (2024-2029).” This comprehensive report forecasts the global pharma R&D services market to reach approximately $129 billion by 2029, growing at a compound annual growth rate (CAGR) of 5% from an estimated $101 billion in 2024.
Worldwide Single Cell Analysis (SCA) Market Forecasted to Grow at 10% p.a., Reaching $2.1B by 2029 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, “Single-Cell Analysis (SCA): Market Size, Segmentation, Growth, Competition, and Trends (2024-2029),” the global single-cell analysis market is predicted to reach $2.1B by 2029. This growth will be driven by broader adoption across both biopharma and academia, falling costs enabling higher throughput experiments, and increasing use of newer assays, particularly those supporting FFPE- and multomics-based analysis.
Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 29% p.a., Reaching $10.1B by 2029 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, “Oncology Liquid Biopsy (LBx) Market Report 2024 – 2029,” the global oncology liquid biopsy market is predicted to reach $10.1B by 2029, driven by a broad push for increased biomarker testing globally, updated testing guidelines, and expansion in coverage for testing.
DeciBio Forecasts the Spatial Biology Market, Growing at 21% p.a. to Reach $2.27B in 2029 - Market Report by DeciBio Consulting LLC
DeciBio Consulting LLC’s latest market report, “Spatial Biology Market Report, Second Edition: 2024-2029,” states that the global spatial biology market is predicted to reach $2.27B by 2029.
DeciBio Forecasts the Rise of Allogeneic Therapies to Fuel the Worldwide Cell Therapy R&D and Manufacturing Market, Growing at 21% p.a. to Reach $14.5B by 2028 - Market Report by DeciBio Consulting LLC
DeciBio Consulting LLC’s latest market report, “Cell Therapy Manufacturing Global Market Report, First Edition: 2023-2028,” states that the global cell therapy manufacturing market, driven by innovation in manufacturing tools and the number of expected approvals in the near-term, is predicted to reach $14.5B by 2028.
Worldwide Single Cell Analysis (SCA) Market Forecasted to Grow at 13% p.a. over the Next Three Years, Reaching $1.7B by 2025 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, Single-Cell Analysis (SCA): Market Size, Segmentation, Growth, Competition, and Trends (2019-2025), the global single-cell analysis market is predicted to reach $1.7B by 2025. This growth will be driven by expansion in new applications and offerings, such as FFPE-compatibility and instruments for low- and high-throughput customers.
Worldwide NGS Market Forecasted to Grow at 15% p.a., to Reach ~$9.3B in 2025 – Market Report by DeciBio Consulting
DeciBio Consulting LLC’s latest market report, “Next Generation Sequencing (NGS) Market Size, Growth and Trends (2019-2025),” predicts that the Next generation Sequencing market will grow to ~$9.3 billion (USD) in 2025 driven primarily by clinical adoption in oncology settings across the patient journey, including early detection and monitoring.
Worldwide Spatial Biology Market Forecasted to Grow at 30% p.a., Reaching ~$1.2B by 2027 – Market Report by DeciBio Consulting
DeciBio Consulting LLC’s latest market report, “DeciBio Spatial Biology Market Report 2022,” states that the global spatial biology market — driven by steady growth in academia and accelerated growth in biopharma and CROs, particularly within clinical trials — is predicted to reach $1.2B by 2027.
Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 46% p.a., Reaching $8.6B by 2027 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, “Oncology Liquid Biopsy (LBx) Market Report 2022 - 2027,” the global oncology liquid biopsy market, driven by growth in new applications – primarily minimum residual disease (MRD) testing, serial monitoring, and early cancer detection – is predicted to reach $8.6B by 2027.
